Published in Infect Dis Obstet Gynecol on March 14, 2010
Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother (2014) 0.97
Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females. ISRN Obstet Gynecol (2011) 0.89
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review. J Adolesc Health (2012) 0.89
Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors. PLoS One (2012) 0.88
Survey of human papillomavirus types and their vertical transmission in pregnant women. BMC Infect Dis (2013) 0.85
Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort. J Transl Med (2014) 0.82
Early-life exposures to infectious agents and later cancer development. Cancer Med (2015) 0.82
Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study. BMC Oral Health (2012) 0.79
Human Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery. Infect Dis Obstet Gynecol (2016) 0.76
Human papillomavirus in infants: transmission, prevalence, and persistence. J Pediatr Adolesc Gynecol (2011) 0.76
Contributory role of viral infection in congenital tumour development. Ecancermedicalscience (2013) 0.75
The Prevalence of Human Papillomavirus between the Neonates and Their Mothers. Biomed Res Int (2015) 0.75
Potentiation of human papilloma vaccine candidate using naloxone/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine. Iran J Basic Med Sci (2016) 0.75
Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative. J Transl Med (2015) 0.75
Is administration of the HPV vaccine during pregnancy feasible in the future? Expert Rev Vaccines (2013) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Epidemiology of genital human papillomavirus infection. Am J Med (1997) 4.09
Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis (1999) 4.05
Detection of sickle cell anaemia and thalassaemias. Nature (1987) 3.94
The epidemiology of human papillomavirus infections. J Clin Virol (2005) 3.63
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59
The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52
High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev (2001) 2.38
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol (1998) 1.84
Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis (2004) 1.80
Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis (2002) 1.77
Transmission of human papillomaviruses from mother to child. Aust N Z J Obstet Gynaecol (1993) 1.63
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer (2003) 1.55
Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol (2005) 1.44
Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17
Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol (1995) 1.12
Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol (1997) 1.11
p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.08
Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol (1998) 1.06
Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol (1999) 1.04
Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS (2007) 1.00
Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev (1995) 0.94
The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev (1991) 0.94
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read (2000) 0.91
Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Int J STD AIDS (2003) 0.91
Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection. J Gen Virol (1996) 0.90
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. Eur J Clin Microbiol Infect Dis (2006) 0.88
Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients. Arch Virol (1997) 0.78
Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst (2004) 3.43
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J (2007) 1.88
Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis (2004) 1.80
Competency assessment of residents in surgical pathology using virtual microscopy. Hum Pathol (2009) 1.54
Possible avian influenza (H5N1) from migratory bird, Egypt. Emerg Infect Dis (2007) 1.53
Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39
P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol (2007) 1.30
Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control (2010) 1.30
Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion--absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol Clin Exp Res (2007) 1.29
Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27
Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) (2004) 1.22
Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev (2005) 1.13
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer (2010) 1.12
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer (2008) 1.05
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology (2002) 1.03
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer (2011) 1.01
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol (2008) 0.99
Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord (2002) 0.98
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomarkers Prev (2008) 0.96
An exercise program to improve fall-related outcomes in elderly nursing home residents. Appl Nurs Res (2004) 0.95
Siblings' coping strategies and mental health services: a national study of siblings of persons with schizophrenia. Psychiatr Serv (2008) 0.95
Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer (2010) 0.93
Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urol Oncol (2012) 0.91
Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol (2007) 0.91
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs. J Virol (2009) 0.90
Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer (2011) 0.90
Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol (2006) 0.89
Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev (2003) 0.88
Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomarkers Prev (2009) 0.88
Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras. Virology (2006) 0.87
Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One (2011) 0.87
Markers of HPV infection and survival in patients with head and neck tumors. Int J Cancer (2013) 0.86
Functional mapping of the human papillomavirus type 16 E1 cistron. J Virol (2008) 0.86
Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology (2010) 0.83
HPV persistence and its oncogenic role in prostate tumors. J Med Virol (2012) 0.83
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis (2009) 0.81
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site. J Gen Virol (2009) 0.81
Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay. Curr Protoc Microbiol (2014) 0.79
Preparedness for natural disasters among older US adults: a nationwide survey. Am J Public Health (2014) 0.78
Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation. Virology (2009) 0.77
A Web-based database for pathology faculty effort reporting. Hum Pathol (2008) 0.75
Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients. Acta Haematol (2017) 0.75
Communication via the statistics of photon-number squeezed light. Phys Rev Lett (2005) 0.75